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Abstract
AIM: To investigate the aberrant expression of nuclear 
matrix proteins in human gastric cancer cells before and 
after hexamethylene bisacetamide (HMBA) treatment. 
METHODS: Proteomics analysis of differential nuclear 
matrix proteins was performed by two dimensional 
electrophoresis polyacrylamide gel electrophoresis and 
matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry. The expression levels of three nu-
clear matrix proteins were further confirmed by Western 
blotting and their locations in nuclear matrix filament 
were observed by quantum dots-based immunofluores-
cence.
RESULTS: Proteomics analysis showed that 43 protein 
spots were significantly changed due to HMBA treat-
ment. Fifteen proteins were identified in the HMBA-
induced differentiation of gastric tumor cells. Eight 
proteins spots were down-regulated while seven were 
up-regulated. Among these proteins, prohibitin, nu-
cleophosmin and hnRNP A2/B1 were significantly de-
creased in HMBA-treated human gastric cancer cells, 
and their locations in nuclear matrix were altered by 
HMBA. Our results proved the alteration of specific 
nuclear matrix proteins during the differentiation of 
human gastric cancer cells. And the aberrant expres-
sions of nuclear matrix proteins were of significance in 
revealing the regulatory mechanism of tumor cell pro-
liferation and differentiation. 
CONCLUSION: The aberrant expressions and intracel-
lular redistributions of nuclear matrix proteins before 
and after HMBA treatment indicated that nuclear ma-
trix proteins play a pivotal role in the differentiation of 
gastric cancer cells.
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
Gastric cancer is the most common malignant gastro-
intestinal cancer, which accounts for 25% of  cancer 
BRIEF ARTICLE 
World J Gastroenterol  2010 May 7; 16(17): 2176-2182
 ISSN 1007-9327 (print)
© 2010 Baishideng. All rights reserved.
Online Submissions: http://www.wjgnet.com/1007-9327office
wjg@wjgnet.com
doi:10.3748/wjg.v16.i17.2176
Jing GJ et al . Nuclear matrix proteins and gastric cancer
deaths[1]. Researches on gastric cancer cell differentia-
tion will not only contribute to the diagnosis of  gastric 
cancer, but also the regulatory mechanism of  tumor 
cell differentiation. Studies have been carried out on the 
mechanism of  induced differentiation of  gastric cancer 
cells. But reports about the proteins related to the dif-
ferentiation and proliferation of  gastric cancer are rare. 
It is important to elucidate the regulatory mechanism 
of  gastric cancer cell differentiation. Nuclear matrix is a 
filamentous protein framework for eukaryotic cell chro-
matin. Nuclear matrix proteins closely relate to DNA 
duplication and transcription[2]. Some regulatory proteins 
or enzymes are nuclear matrix proteins or nuclear ma-
trix-binding proteins[3], and they regulate cell differentia-
tion. Protein components of  nuclear matrix are dynamic 
throughout cell proliferation and differentiation. Protein 
composition of  nuclear matrix in tumor cells differ from 
normal tissue-derived cells[4]. In our previous study we 
found that the protein compositions of  nuclear matrix 
were changed during the induced-differentiation of  vari-
ous tumor cells[5,6], suggesting that analysis on the aber-
rant expression of  nuclear matrix proteins was of  great 
importance for an in-depth investigation in the mecha-
nism of  cell carcinogenesis and reversal. Hexamethylene 
bisacetamide (HMBA) is a hybrid bipolar compound and 
originally developed as a potent inducer of  cell differen-
tiation[7]. Hereby, based on the induced effects of  HMBA 
on the differentiation of  human gastric cancer cells[8,9], 
we extended our study to determine the aberrant expres-
sion of  nuclear matrix proteins in HMBA-treated human 
gastric adenocarcinoma BGC-823 cells. We aimed to 
identify specific nuclear matrix proteins related to gastric 
cancer cells and provide further scientific evidences for 
the mechanism of  gastric cancer cell proliferation and 
differentiation.
MATERIALS AND METHODS
Cell culture
BGC-823 cells, obtained from China Center for Type 
Culture Collection, were routinely cultured in RPMI 1640 
(Gibco) supplemented with 10% heat-inactivated fetal 
bovine serum (FBS; Hyclone) and 100 U/ml penicillin, 
100 μg/ml streptomycin and 50 μg/ml kanamycin at 
37℃ in a humidified atmosphere containing 5% CO2. 
Whole cell and nuclear matrix lysates preparation
To prepare the whole cell extracts, cells were washed 
in phosphate buffered saline (PBS) and then lysed in 
ice-cold lysis buffer {7 mol/l urea, 2 mol/l thio-
urea, 4% 3-[(3-Cholanidopropyl)dimethylammonio]-
1-propanesulfonate (CHAPS), 1.5% Triton X-100, 1% 
pharmalyte (pH 3-10 Bio-rad), 65 mmol/l Dl-Dithio-
threitol (DTT), 40 mmol/l Tris, 5 mg/ml aprotinin, 
1 mg/ml leupeptin, 1 mg/ml pepstatin, 2 mmol/l 
phenylmethanesulfonyl fluoride (PMSF), and 5 mmol/L 
ethylenediaminetetraacetic acid (EDTA)}. The suspen-
sion was then sonicated for 20 min at 0℃ and centri-
fuged at 8000 × g for 30 min.
Nuclear matrix proteins were prepared using a method 
described by Michishita et al[10]. After washed in ice-cold 
PBS twice, BGC-823 cells were suspended in cytoskel-
eton (CSK) buffer [100 mmol/l KCl, 3 mmol/l MgCl2, 
5 mmol/l ethylene glycol tetraacetic acid, 10 mmol/l pi-
perazine-N,N’-bis(2-ethanesulfonic acid), 300 mmol/l su-
crose, 0.5% Triton X-100, and 2 mmol/l PMSF, pH 6.8] 
for 10 min at 0℃. After being centrifuged at 1000 × g 
for 5 min, the pellet was resuspended in digestion buffer 
(identical to CSK buffer except for 50 mmol/l NaCl 
instead of  KCl) containing 400 mg/ml DNase Ⅰ for 
30 min at room temperature and centrifuged at 1000 
× g twice. Cold ammonium sulfate at a final concentra-
tion of  0.25 mol/l was used to precipitate proteins. 
After centrifugation, the pellet was dissolved in lysis 
buffer [7 mol/l urea, 2 mol/l thiourea, 4% CHAPS, 
1.5% Triton X-100, 1% Pharmalyte (pH 3-10 Bio-rad), 
65 mmol/l DTT, 40 mmol/l Tris, 5 mg/ml aprotinin, 
1 mg/ml leupeptin, 1 mg/ml pepstatin, 2 mmol/l 
PMSF, and 5 mmol/l EDTA] and then sonicated at 0℃ 
for 20 min. Finally, the suspension was centrifuged at 
10 000 × g at 4℃ for 30 min and the supernatants were 
used as nuclear matrix extracts.
Protein concentrations were determined by BCA assay.
Two dimensional electrophoresis, matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry 
analysis and protein identification
2-D polyacrylamide gel electrophoresis (PAGE) was per-
formed as follows. Protein lysates were diluted in sample 
buffer with 2% Immobiline™ DryStrip gel (IPG) buffer, 
pH 3-10, nonlinear (GE Heathcare). The samples were 
applied to 18 cm, immobilized pH gradient strips of  pH 
3-10 (IPG Drystrips, GE Healthcare). After isoelectric 
focusing was completed, the strips were equilibrated 
and the second dimensional electrophoresis was carried 
out overnight at 3 W/gel at 20℃. The triplicate sets of  
silver-stained gels were scanned using a UMAX POWER 
LOOK Ⅲ photometer and analyzed with the PD Quest 
8.0 software (Bio-rad). The digitalized two dimensional 
electrophoresis (2-DE) gel images were compared by 
matching method. Differentially expressed spots were 
analyzed and annotated.
The spots were cut and digested using 12.5 ng/μl 
trypsin (Promega, Madison, WI, USA) in 50 mmol/l 
ammounium bicarbonate (pH 8.0, Sigma). After that 
the samples were eluted with 2 μl of  matrix solution 
containing 10 mg/ml α cyano-4-hydroxy cinnamic acid 
(CHCA, Sigma) and were submitted to Bruker Ⅲ matrix-
assisted laser desorption/ionization time-of-flight mass 
spectrometer. The spectra were internally calibrated us-
ing the trypsin autolysis products [842.51 (M + H) and 
2211.11 (M + H)] by Flex Analysis software and searched 
against Swiss-prot and NCBI database using the Mascot 
tool from matrix science. All the searches were analyzed 
with a 50 ppm mass tolerance.
Western blotting
For Western blotting experiments, 20 μg cell lysates were 
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loaded and separated on polyacrylamide gles and then 
transferred to positively-charged nylon membranes (Mil-
lipore, Bedford, MA) according to standard protocol. 
These blots were blocked for 1 h at room temperature 
in 5% skim milk. The target proteins were probed with 
primary antibodies and horseradish peroxidase-labeled 
secondary antibodies (Santa Cruz). β-actin was used as 
an indicator for equality of  lane loading. Antibody posi-
tive bands were visualized using ECl Western blotting 
detection reagents (Pierce). The X-ray film was scanned 
and the band density was calculated using the ImageJ 
software[11].
Quantum dots-based sample preparation for 
fluorescence microscopy
The NM-IF system was prepared according the methods 
described by liang et al[12]. After being prefixed with 4% 
paraformaldehyde at room temperature for 10 min, the 
cover slips were blocked with 3% bovine serum albumin 
for 1 h and then incubated with nucleophosmin (NPM), 
prohibitin (PHB) and hnRNP A2/B1 primary antibodies 
at 37℃ for 1 h. After washing, the cover slips were rinsed 
in biotin-labeled secondary antibodies for 45 min at 37℃, 
washed with tris-buffered saline Tween-20, and incubated 
with streptavidin-conjugated quantum dots (size scale, 
605 nm) for 1 h at 37℃. After that, the cover slips were 
enveloped with 90% glycerol and observed under fluo-
rescence microscope. 
RESULTS
Proteomics analysis of BGC-823 cells before and after 
HMBA treatment 
For proteomics analysis, cell lysates from control and 
HMBA-treated cells were submitted to 2D-PAGE fol-
lowed by silver-staining of  the gel. The procedures were 
independently repeated three times and the representa-
tive gel images are shown in Figure 1A. And Figure 1B 
displayed the enlarged maps of  changed expression of  
nuclear matrix proteins from BGC-823 cells. PD Quest 
8.0 software (Bio-rad) detected about 342 ± 10 pro-
teins spots on the silver-stained gels of  control group 
while 280 ± 13 protein spots of  HMBA-treated group, 
suggesting that the result of  2-DE PAGE had a high 
repeatability. Forty-three changed spots were excised 
and digested with trypsin, and were identified by mass 
spectrometry. Fifteen proteins were identified in the 
HMBA-induced differentiation of  gastric tumor cells. 
The identified proteins are listed in Table 1. The expres-
sions of  Zinc finger protein 268, calcium-binding pro-
tein CaBP5, MAGUK p55 subfamily member 3, vacu-
olar protein sorting 33B, and Ras-related protein Rab-30, 
Vimentin, Calnexin (Precursor) were up-regulated while 
peroxiredoxin 2, transcriptional repressor CTCFl, PHB, 
Keratin 1 type Ⅱ cytoskeletal, PACAP protein, hnRNP 
A2/B1, C-type lectin and NPM were down-regulated. 
Another 28 protein spots were not identified for their 
low abundances. We next focused on PHB, NPM and 
hnRNP A2/B1, which were also identified as aberrantly 
expressed proteins in our previously studies[12-15].
Immunoblotting confirmation of differentially expressed 
nuclear matrix proteins
To further verify the aberrant changes of  PHB, NPM 
and hnRNP A2/B1, Western immunoblotting was em-
ployed to confirm the expression levels of  these proteins 
in cells before and after HMBA treatment, and the in-
tensities of  protein bands were densitometrically quanti-
fied as described by Sheffield JB[11]. Results showed that 
signals of  PHB, NPM and hnRNP A2/B1 in HMBA-
treated cells were much lower than that in control cells, 
suggesting that the expressions of  these three proteins at 
7 d of  treatment were significantly inhibited by HMBA 
(Figure 2). All the Western blotting results were consis-
tent with the proteomic analysis.
Localization of PHB, NPM and hnRNP A2/B1 in NM-IF 
system before and after HMBA treatment
Proteomics analysis showed that PHB, NPM and hnRNP 
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Table 1  Differentially expressed nuclear matrix proteins identified by mass spectrum
Spot number Protein name Accession number Mol. mass calc (Da) pI (calc) Score
Up-regulated proteins
   L1 Zinc finger protein 268 Q14587 108 373 9.14   57
   L2 Calcium-binding protein CaBP5 Q9NP86   19 812 4.46   61
   L3 MAGUK p55 subfamily member 3 Q13368   66 168 6.27   45
   L4 Vacuolar protein sorting 33B Q9H267   70 570 6.29   54
   L5 Ras-related protein Rab-30 Q15771   23 058 4.91   64
   L6 Vimentin 57471646   49 623 5.19   48
   L7 Calnexin (Precursor) 4262127   10 638 5.30   89
Down-regulated protein
   L8 Peroxiredoxin 2 P32119   21 892 5.66   72
   L9 Transcriptional repressor CTCFL Q8NI51   75 668 8.58   67
   L10 Prohibitin P35232   29 859 5.57   79
   L11 Keratin 1, type Ⅱ, cytoskeletal 7428712   65 455 6.03   86
   L12 PACAP protein 18204192   20 681 5.37 161
   L13 hnRNP A2/B1 P22626   36 600 8.67   97
   L14 C-type lectin Q2K157   22 130 5.47   68
   L15 Nucleophosmin Q96EA5   32 726 4.64   76
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A2/B1 were nuclear matrix proteins. QDs-based location 
experiments were conducted to corroborate the altera-
tion of  the physical distribution of  these three proteins 
in nuclear matrix-intermediate system. Clearly altered 
distribution patterns for NPM and hnRNP A2/B1 were 
observed in the nucleus while PHB in at the cytoplasm. 
The red fluorescence representing PHB mainly accumu-
lated at the nucleus periphery in control cells (Figure 3C), 
while PHB was uniformly distributed in the whole cy-
toplasm after HMBA treatment, suggesting that HMBA 
obviously altered the location of  PHB (Figure 3D). Highly 
intensified NPM fluorescence mainly localized in the 
residue of  nucleoli in correspondence with the fact that 
NPM was an established marker for the granular com-
ponents[16], with very subtle expression in the cytoplasm 
(Figure 3A). HMBA treatment resulted in the low inten-
sity of  fluorescence in nucleolus and faint fluorescence in 
cytoplasm derived from NPM, suggesting that NPM had 
a tendency of  translocation from nucleoli regions to nu-
clear matrix (Figure 3B). When referred to hnRNP A2/
B1, a similar distribution pattern to NPM was observed. 
In control cells, the fluorescence representing hnRNP 
A2/B1 was mainly detected in nuclear region with subtle 
signals in cytoplasm region (Figure 3E), whereas after 
HMBA treatment, a clear translocation appeared from 
nuclear to cytoplasm region, and hnRNP A2/B1was uni-
formly distributed in the cytoplasm but not in the nucleus 
(Figure 3F).
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Figure 1  Two-dimensional protein profiles from the nuclear matrix of BGC-823 cells. A: Representative two-dimensional protein profiles from the nuclear matrix 
of BGC-823 cells before and after hexamethylene bisacetamide (HMBA) treatment. The differentially expressed proteins are marked with circular symbols on the gels. 
L1-L7 spots indicate the up-regulated proteins while L8-L15 indicates the down-regulated proteins; B: Enlarged portions from 2-DE gels.
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DISCUSSION
The alteration of  nuclear matrix components is closely 
related to cell carcinogenesis. Configuration and protein 
composition of  nuclear matrix in tumor cells differ from 
normal tissue-derived cells. For further investigating 
the effects of  HMBA on the protein components of  
nuclear matrix of  human gastric cancer cells, proteomics 
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Figure 2  Determination of prohibitin (PHB), nucleophosmin (NPM) and hnRNP A2/B1 at nuclear matrix proteins and whole cell proteins by Western immu-
noblotting. All of these three protein signals were found to be down-regulated at whole cell level and nuclear matrix level after HMBA treatment.
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Figure 3  Effects of HMBA treatment on the localization of differentially expressed nuclear matrix proteins in NM-IF system as shown by a quantum dots-
based immnuofluorescence. Typical changes of localization of NPM (A, B), PHB (C, D) and hnRNP A2/B1 (E, F) are observed after treatment with 5 mmol/L HMBA. 
The figure is composed of representative pictures taken from three independent experiments. A, C, E: Control; B, D, F: HMBA.
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analysis was employed to screen the aberrant nuclear 
matrix proteins of  human gastric cancer cells before and 
after HMBA treatment. And 15 differentially expressed 
proteins were identified, seven of  which, including Zinc 
finger protein 268, nebulin, etc. were up-regulated while 
the other eight proteins, including PHB, KeHMBAtin 
1 type Ⅱ, cytoskeletal, hnRNP A2/B1, NPM, etc. were 
down-regulated. Getzenberg et al[17] reported that nuclear 
matrix profiles of  bladder cancer, liver cancer and colon 
cancer were significantly altered in comparison with that 
of  the normal tissues; moreover, differential nuclear 
matrix proteins were tumor-specific[17-19]. In our previous 
studies, we found variational nuclear matrix profiles of  
tumor cells[5,6]. HMBA could change protein composi-
tions of  gastric cancer cell nuclear matrix. The alteration 
of  nuclear matrix protein expressions during the dif-
ferentiation of  gastric cancer cells was closely related to 
their functional transformation.
In this article we focused on the aberrant expression 
of  nuclear matrix proteins in the induced-differentiation 
of  gastric cancer cells. Among all the differentially ex-
pressed proteins, the down-regulated proteins, PHB, 
NPM and hnRNP A2/B1, were also identified in our 
previous studies on the induced differentiation of  gas-
tric cancer MGC80-3 cells, suggesting that PHB, NPM 
and hnRNP A2/B1 were common aberrantly expressed 
nuclear matrix-specific proteins in different tumor cell 
lines[8,12-15]. Proteomics analysis showed that expressions 
of  PHB, NPM and hnRNP A2/B1 were down-regulated 
both in the whole cell lysates and nuclear matrix lysates, 
and the expression changes were further confirmed by 
Western blotting. Quantum dots-based immunofluores-
cent assay was performed to investigate the localization 
of  specific nuclear matrix proteins in nuclear matrix-
intermediate filament system. And results displayed that 
PHB, NPM and hnRNP A2/B1 were localized in nuclear 
matrix fibers, and their locations were altered by HMBA 
treatment. Our data further proved that PHB, NPM and 
hnRNP A2/B1 were common differential nuclear matrix 
proteins. And the aberrant expression and relocation of  
these three proteins were closely related to their regula-
tory roles in the process of  tumor cell differentiation.
The importance of  differentially expressed nuclear 
matrix proteins was embodied not only by their loca-
tions in nuclear matrix fibers but also their regulations 
on cell differentiation and apoptosis. For example, PHB 
presented anti-proliferation activities by inhibiting the 
activity of  nuclear estrogen receptors, and it was usu-
ally over-expressed in tumor tissues[20]. PHB was also 
a biomarker protein for differentiating benign prostate 
hyperplasia from prostate cancer[21]. NPM was an abun-
dant nucleolar phosphoprotein, and it could cause the 
suppression of  cell differentiation and anti-apoptosis in 
human carcinogenesis. Inhibiting the activity of  NPM 
led to the over-expression of  P53[22]. Cell proliferation 
could be inhibited by blocking the shuttle of  NPM from 
nuclear to cytoplasm[23]. hnRNP A2/B1 played a pivotal 
role in DNA damage repair[24]. The expression and loca-
tion of  PHB, NPM and hnRNP A2/B1 were changed 
in gastric tumor cells before and after HMBA treatment, 
suggesting their pivotal biological functions in the differ-
entiation of  gastric tumor cells. Continued investigation 
on specific nuclear matrix proteins will contribute to bet-
ter understanding the regulatory mechanisms of  nuclear 
matrix proteins in gastric carcinogenesis and reversal.
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